What is 603392.SS's market cap?

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (603392.SS) has a market capitalization of approximately $36.74 billion, as of July 23, 2026, based on the most recent share price and shares outstanding.

Does 603392.SS pay a dividend?

Yes — Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (603392.SS) has a dividend payment history. The most recent payment, frequency, and full history are on the Dividend tab.

Is 603392.SS profitable?

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (603392.SS) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

603392.SS

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.

SHH·Biotechnology · Healthcare

¥29.06¥0.34−1.16%

Market cap¥36.74B·Market closed·Jul 23 5:20 AM UTC

Price Chart

¥29.06−¥0.34 (−1.16%)today

−72.88%CAGR −22.97%

Select date range

FromTo

Apr 29, 2020Jul 23, 2021 → Jul 23, 2026· 5.0 yrsJul 23, 2026

Key Metrics

DividendDividend Tab

Dividend Yield (FWD)0.00%

Annual Dividend (FWD)¥0.00

Dividend Growth (5Y)—

Dividend Safety—

Payout Ratio—

FCF Payout Ratio—

Most Recent Dividend¥0.320

Ex-Dividend DateJun 3

Payment DateJun 3

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings DateAug 20

Last Report DateApr 20

Reported vs Estimate−¥0.18

Earnings Surprise—

FinancialsFinancials Tab

Revenue¥1.94B

Net Income−¥388.47M

Net Margin−20.0%

Operating Cash Flow¥94.32M

Capital Expenditures¥750.09M

Free Cash Flow−¥655.77M

Return on Equity−3.3%

Return on Invested Capital−0.5%

Net Cash¥3.59B

Analyst Estimates

PRO

Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.

Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for 603392.SS and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how 603392.SS's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for 603392.SS and 80,000+ other tickers.

About Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. is a biopharmaceutical firm that handles the entire process from research and development to the production, marketing, and distribution of diagnostic solutions for infectious diseases and various vaccines. The company operates extensively across China and in international markets. Its comprehensive product range offers diagnostic test kits for a multitude of infectious agents, including COVID-19, HIV, HTLV, Hepatitis, EV-71, and Tuberculosis. It also provides specific detection reagents for Hepatitis C and Syphilis. Beyond these, the…

CEO: Qiu Zixin
Sector: Healthcare
Industry: Biotechnology
Exchange: SHH
Employees: 4,116
Website: www.ystwt.com

Peers

Peers Tab

300255.SZ

Hebei Changshan Biochemical Pharmaceutical Co., Ltd.

Cap

¥25.1B

002653.SZ

Haisco Pharmaceutical Group Co., Ltd.

Cap

¥81.7B

688331.SS

RemeGen Co. Ltd. Class A

Cap

¥69.3B

Latest News

News Tab

No recent news available.

Frequently Asked Questions About 603392.SS

What does Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. do?: Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (603392.SS) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is 603392.SS's market cap?: Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (603392.SS) has a market capitalization of approximately $36.74 billion, as of July 23, 2026, based on the most recent share price and shares outstanding.
Does 603392.SS pay a dividend?: Yes — Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (603392.SS) has a dividend payment history. The most recent payment, frequency, and full history are on the Dividend tab.
Is 603392.SS profitable?: Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (603392.SS) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.